| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018589 |
| Receipt No. | R000018657 |
| Official scientific title of the study | Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study |
| Date of disclosure of the study information | 2015/08/10 |
| Last modified on | 2018/02/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Japan PHarmacological Audit study of Safety and Efficacy in Realworld (Phase-R) Delirium Study
|
|
| Title of the study (Brief title) | Phase-R Delirium Study
|
|
| Region |
|
|
| Condition | ||||
| Condition | Malignancy | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Malignancy | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To evaluate the safety and efficacy of antipsychotic treatments for delirium in palliative care units and psychooncology consultation settings. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Delirium Rating Scale R-98 on day 3 |
| Key secondary outcomes | NuDESC item 2-4
Communication Capacity Scale item 4 Agitation Distress Scale item 2 Adverse events Drug-induced Extra-piramidal Symptom Scale(DIEPSS) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inpatients with advanced cancer aged 18 years or older who undergo antipsychotic treatments for hyper- or hypoactive delirium in palliative care units or psycho-oncology consultation settings | |||
| Key exclusion criteria | Patients with substance withdrawal delirium
Patient with postoperative delirium Patients who undergo medical treatments intended to terminal sedation |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Asao Ogawa |
| Organization | National Cancer Center East |
| Division name | Psycho-Oncology Division |
| Address | 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan |
| TEL | 04-7133-1111 |
| asogawa@east.ncc.go.jp | |
| Public contact | |
| Name of contact person | Keisuke Ariyoshi |
| Organization | The University of Tokyo, The Institute of Medical Science |
| Division name | Department of Palliative Medicine |
| Address | 4-6-1 Shiroganedai, Minato-ku, Tokyo, Japan |
| TEL | 03-3443-8111 |
| Homepage URL | http://www.jortc.jp/ |
| k-ariyoshi@umin.ac.jp | |
| Sponsor | |
| Institute | The University of Tokyo, The Institute of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立がん研究センター東病院(千葉県)
国立がん研究センター中央病院(東京都) 名古屋市立大学大学院(愛知県) 岡山大学病院(岡山県) 千葉県がんセンター(千葉県) 市立札幌病院(北海道) 埼玉県立がんセンター(埼玉県) 東京大学医学部附属病院(東京都) 滋賀医科大学(滋賀県) 国立病院機構 近畿中央胸部疾患センター(大阪府) 慶應義塾大学病院(東京都) 聖隷三方原病院(静岡県) 小牧市民病院(岐阜県) 外旭川病院(秋田県) 川崎市立井田病院かわさき総合ケアセンター(神奈川県) 筑波メディカルセンター病院(茨城県) ガラシア病院(大阪府) 聖路加国際病院(東京都) 栃木県立がんセンター(栃木県) 岡山済生会総合病院(岡山県) 六甲病院(兵庫県) 大阪市立総合医療センター(大阪府) 東北大学病院(宮城県) 島根大学医学部附属病院(島根県) JCHO東京新宿メディカルセンター(東京都) 兵庫県立加古川医療センター(兵庫県) 永寿総合病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Safety (Day7) and efficacy (Day3) of antipsychotic treatments for hyper- and hypoactive delirium will be evaluated |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018657 |